ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

November 3, 2006

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

Special Issue: Broder Resigns NCI To Take Job With Drug Company IVAX

December 22, 1994

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989

NCI Information Officer Plays Key Role In Cancer Program

February 8, 1980

CCOP Review Competed, Enough Good Applications In Funding Range To Get Viable Program Started

February 18, 1983